参考文献/References:
[1] Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66:115-132.
[3] Wei W,Zeng H,Zheng R,et al.Cancer registration in China and its role in cancer prevention and control[J].Lancet Oncol,2020,21(7):e342-e349.
[4] Wang J,Yu F,Shang Y,et al.Thyroid cancer:Incidence and mortality trends in China,2005-2015[J].Endocrine,2020,68(1):163-173.
[5] Cabanillas ME,McFadden DG,Durante C.Thyroid cancer[J].Lancet,2016,388(10061):2783-2795.
[6] Giuffrida D,Gharib H.Anaplastic thyroid carcinoma:Current diagnosis and treatment[J].Ann Oncol,2000,11(9):1083-1089.
[7] Fagin JA,Wells SA.Biologic and clinical perspectives on thyroid cancer[J].N Engl J Med,2016,375(23):2307.
[8] Warburg O.On the origin of cancer cells[J].Science,1956,123(3191):309-314.
[9] Deberardinis RJ,Cheng T.Q's next:The diverse functions of glutamine in metabolism,cell biology and cancer[J].Oncogene,2010,29(3):313-324.
[10] Hensley CT,Wasti AT,Deberardinis RJ.Glutamine and cancer:Cell biology,physiology,and clinical opportunities[J].J Clin Invest,2013,123(9):3678-3684.
[11] Son J,Lyssiotis CA,Ying H,et al.Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway[J].Nature,2013,496(7443):101-105.
[12] Lane AN,Fan TW.Regulation of mammalian nucleotide metabolism and biosynthesis[J].Nucleic Acids Res,2015,43(4):2466-2485.
[13] Weinberg F,Hamanaka R,Wheaton WW,et al.Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity[J].Proc Natl Acad Sci USA,2010,107(19):8788-8793.
[14] Godwin AK,Meister A,Odwyer PJ,et al.High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis[J].Proc Natl Acad Sci USA,1992,89(7):3070-3074.
[15] Gao P,Tchernyshyov I,Chang TC,et al.C-myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism[J].Nature,2009,458(7239):762-765.
[16] Wise DR,Deberardinis RJ,Mancuso A,et al.Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction[J].Proc Natl Acad Sci USA,2008,105(48):18782-18787.
[17] Hao Y,Samuels Y,Li Q,et al.Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer[J].Nat Commun,2016,20(7):11971.
[18] Laplante M,Sabatini DM.MTOR signaling in growth control and disease[J].Cell,2012,149(2):274-93.
[19] Yu Y,Yu X,Fan C,et al.Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer[J].J Mol Med(Berl),2018,96(8):777-790.
[20] Chen Z,Lin J,Feng S,et al.SIRT4 inhibits the proliferation,migration,and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism[J].Onco Targets Ther,2019,28(12):2397-2408.
[21] Xiang Y,Stine ZE,Xia J,et al.Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis[J].J Clin Invest,2015,125(6):2293-2306.
[22] Gross MI,Demo SD,Dennison JB,et al.Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer[J].Mol Cancer Ther,2014,13(4):890-901.
[23] Jacque N,Ronchetti AM,Larrue C,et al.Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition[J].Blood,2015,126(11):1346-1356.